Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1988 Sep;27(2):128–132. doi: 10.1007/BF00200016

In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor

R Voth 1, S Rossol 1, H Gallati 2, I Pracht 2, H P Laubenstein 1, G Hess 1, W E G Müller 3, H C Schröder 3, C Jochum 1, K H Meyer zum Büschenfelde 4,
PMCID: PMC11038699  PMID: 2458181

Abstract

The natural killer (NK) cell activity of mice in the peritoneal cavity is very low or undetectable and testing peritoneal NK cells is a useful model for studying the influence of activating substances upon local injection. Injection of tumor necrosis factor (TNF) at doses of 10–200 ng caused a marked activation of NK cell activity which was maximal after 24 h and declined rapidly on day 2. A similar effect was observed when interferons alpha and beta were injected, and there were additive results when interferon was injected together with TNF. The NK cell nature of the effector cells activated by TNF was substantiated by the finding that previous injection with anti-asialo GM 1 antibody prevented activation. Interferon could not be detected in the peritoneal wash fluid after injection of TNF suggesting interferon-independent activation. In further experiments after i.p. injection of TNF peritoneal exudate cells (PECs) only killed YAC-1 targets in a 4-h assay. There was no additional killing in an 18-h assay towards neither YAC-1 cells or P815 cells, suggesting that macrophages were not involved. Furthermore TNF was also active in vitro by activating NK cells in isolated human peripheral blood cells. However in the PECs stimulated in vitro no significant induction of cytotoxic capacities by TNF was measured. Our data suggest that the action of TNF is not restricted to the lysis of tumor cells but can also induce immunological properties in the host defense against virus infections and neoplasms.

Keywords: Interferon, Tumor Necrosis Factor, Natural Killer Cell, P815 Cell, Peripheral Blood Cell

References

  • 1.Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN. Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985;260:2345–2354. [PubMed] [Google Scholar]
  • 2.Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21. 1968;97:77–89. [PubMed] [Google Scholar]
  • 3.Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci. 1975;72:3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Engler H, Zawatzky R, Goldbach A, Schröder CH, Weyand C, Hämmerling GJ, Kirchner H. Experimental infection of inbred mice with HSV. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch Virol. 1982;74:239–247. doi: 10.1007/BF01314157. [DOI] [PubMed] [Google Scholar]
  • 5.Gallati H. Interferon: A greatly simplified enzyme-immunological determination, using two monoclonal antibodies. J Clin Chem Clin Biochem. 1982;20:907–914. [PubMed] [Google Scholar]
  • 6.Gallati H, Pracht I, Schmidt J, Häring P, Garotta G. A simple, rapid and large capacity ELISA for biological active native and recombinant human IFN-gamma. J Biol Regulators Homeostatic Agents. 1987;1(3):109–118. [PubMed] [Google Scholar]
  • 7.Harris R, Ukaejiofo EO. Tissue typing using a routine one-step lymphocyte separation technique. Br J Haematol. 1970;18:229–235. doi: 10.1111/j.1365-2141.1970.tb01436.x. [DOI] [PubMed] [Google Scholar]
  • 8.Herberman RB. NK cells and other natural effector cells. New York: Academic Press; 1982. [Google Scholar]
  • 9.Karen HS, Leung KH. Modulation of human natural killing I. The role of interferons and prostaglandins. J Immunol. 1982;127:2007–2013. [PubMed] [Google Scholar]
  • 10.Kohase M, Henkson-De Stefano D, May LT, Vilcek J, Sehgal DB. Induction of β2 interferon by TNF: a homeostatic mechanism with control of cell proliferation. Cell. 1986;45:659–666. doi: 10.1016/0092-8674(86)90780-4. [DOI] [PubMed] [Google Scholar]
  • 11.Merlin G, Revel M, Wallach D. The interferon-induced enzyme oligolso-adenylate synthetase: rapid determination of its in vitro products. Anal Biochem. 1981;110:190–196. doi: 10.1016/0003-2697(81)90134-2. [DOI] [PubMed] [Google Scholar]
  • 12.Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H. Antiviral effects of recombinant tumor necrosis factor in vitro. Nature. 1986;323:816–819. doi: 10.1038/323816a0. [DOI] [PubMed] [Google Scholar]
  • 13.Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. Induction of natural killer cell activity in mice by injection of indomethacin. Natural Immunity and cell growth regulation. 1986;5(6):317–324. [PubMed] [Google Scholar]
  • 14.Voth R, Chmielarczyk W, Storch E, Kirchner H. Induction of natural killer cell activity in mice by injection of indomethacin. Natural Immunity and cell growth regulation. 1986;5:317–324. [PubMed] [Google Scholar]
  • 15.Voth R, Storch E, Hüller K, Kirchner H. Activation of cytotoxic activity in cultures of bone marrow-derived macrophages by indomethacin. Eur J Immunol. 1987;17:145–148. doi: 10.1002/eji.1830170125. [DOI] [PubMed] [Google Scholar]
  • 16.Zemica D. Human tumor necrosis factor presence structure expression and homology to lymphotoxin. Nature. 1984;312:724–729. doi: 10.1038/312724a0. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES